AutismBelow is a sample of existing clinical evidence:
“The combination of CBMNCs (Cord Blood Mononuclear Cells) and UCMSCs (Umbilical Cord Mesenchymal Stem Cells) showed larger therapeutic effects than the CBMNC transplantation alone… Compared with the Control group, both objective functional and subjective improvements were observed in visual, emotional and intellectual responses, body use, adaption to change, fear or nervousness, nonverbal communication and activity level assessed by CARS (Childhood Autism Rating Scale), as well as in lethargy/social withdrawal, stereotypic behavior, hyperactivity and inappropriate speech evaluated by ABC (Autism Behavior Checklist).”
– “Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism,” Lv et al. Journal of Translational Medicine, 2013
For further information regarding regenerative medicine, please refer to information provided by American Academy of Integrative Cell Therapy (AAICT).